www.chochp.sk - Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals | Katalóg dedo.sk

" rel="bookmark" title="$domena$post_title"?>

Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals // Boehringer Ingelheim ranks among the world // pharmaceutical companies, pharmaceutical jobs, Boehringer Ingelheim, Ingleheim, pharma, animal health, consumer health care, R&D, prescription medicines, biopharmaceuticals, journalists, news releases, Annual Press Conference 2006, facts&figures 2005, clinical trials, Corporate responsibility, research, careers, licensing, job seekers, caring culture, CHC, AH, PM, BI

URL adresa: http://www.chochp.sk

Doplňujúce informácie o webe:
UTF-8





Home Contact Site Map Search Submit Value through Innovation02 August 2015 Media Centre Corporate Profile Global Activities Corporate Responsibility Careers Research & Development Clinical Trials Medical Information Products Partnering Page content jump to main navigation jump to meta navigation Boehringer Ingelheim Resource for Journalists Our Global Activities Our Countries A-Z Albania Argentina Armenia Austria Australia Azerbaijan Bahrain Belarus Belgium Bosnia and Herzegovina Brazil Bulgaria Canada Chile China Colombia Croatia Cyprus Czech Republic Denmark Ecuador Egypt Estonia Ethiopia Finland France Georgia Germany Germany Headquarters Greece Ghana Hong Kong Hungary India Indonesia Iran Irland Israel Italy Japan Jordan Kazakhstan Kenya Kirghizia Kuweit Latvia Lebanon Libya Lithuania Macedonia Malawi Malaysia Malta Mauritius Mexico Moldavia Mongolia Montenegro The Netherlands New Zealand Nigeria Norway Oman Pakistan Peru The Philippines Poland Portugal Quatar Romania Russia Saudi Arabia Seychelles Serbia Singapore Slovakia Slovenia Somalia South Africa South Korea Spain Sudan Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Turkey Turkmenistan USA Uganda Ukraine United Arab Emirates United Kingdom Uruguay Uzbekistan Venezuela Vietnam Yemen for US residents Boehringer Ingelheim Statement Boehringer Ingelheim Statement on Agreement to Sell Roxane Labs to Hikma Pharmaceuticals PLC Latest Press Releases 28.07.2015

Boehringer Ingelheim enters into an exclusive license agreement with Hanmi Pharmaceutical to develop 3rd generation EGFR targeted therapy in lung cancer

24.07.2015

MHRA review confirms benefit/risk profile of Alteplase - the only licensed clot buster for acute ischaemic stroke

15.07.2015

Boehringer Ingelheim Welcomes the Inclusion of OFEV® (nintedanib*) in the Updated International Treatment Guidelines for Idiopathic Pulmonary Fibrosis (IPF)

06.07.2015

Phase III data published in The Lancet Oncology shows a significant overall survival benefit of Giotrif® (afatinib) compared to Tarceva® (erlotinib) in patients with previously treated advanced squamous cell carcinoma of the lung

02.07.2015

New advance in COPD maintenance treatment, Spiolto® Respimat®, approved in first European countries

-

 

Further press releases Biopharmaceuticals Manufacturing. Solutions. Partnering with us Working together Partnership with Ashoka Making More Health Activities back to top Connect with us Facebook - Company Page Instagram Linkedin ...

boehringer, ingelheim, statement, activities, global, search, boehringer ingelheim, 2015 boehringer, 2015 boehringer ingelheim